This statistic shows the global revenue of the Novo Nordisk group from 2007 to 2023, in millions of Danish kroner. In 2022, the group's revenue was approximately *** billion Danish kroner, or about **** billion U.S. dollars.
Novo Nordisk
Novo Nordisk is a Danish pharmaceutical group operating internationally and is headquartered in Bagsværd, near Copenhagen. The company specializes in treatments for diabetes, as well as hemostasis, growth hormone, and hormone therapies. Novo Nordisk was formed in 1989 from the merger of two Danish pharmaceutical companies: Novo Industri and Nordisk Gentofte. Established in France since 1961, Novo Nordisk maintains a production site in Chartres that produces insulin cartridges. The assembly and packaging of insulin injection pens also take place there.
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
Learn more about how ÌÇÐÄÆƽâ°æ can support your business.
Novo Nordisk. (January 31, 2025). Global revenue of the pharmaceutical group Novo Nordisk from 2007 to 2024 (in millions of Danish kroner) [Graph]. In ÌÇÐÄÆƽâ°æ. Retrieved August 06, 2026, from /statistics/1638291/the-commission-has-also-adopted-a-number-of-measures-to-improve-the-quality-of-the-services-provided-by-the-european-union/
Novo Nordisk. "Global revenue of the pharmaceutical group Novo Nordisk from 2007 to 2024 (in millions of Danish kroner)." Chart. January 31, 2025. ÌÇÐÄÆƽâ°æ. Accessed August 06, 2026. /statistics/1638291/the-commission-has-also-adopted-a-number-of-measures-to-improve-the-quality-of-the-services-provided-by-the-european-union/
Novo Nordisk. (2025). Global revenue of the pharmaceutical group Novo Nordisk from 2007 to 2024 (in millions of Danish kroner). ÌÇÐÄÆƽâ°æ. ÌÇÐÄÆƽâ°æ Inc.. Accessed: August 06, 2026. /statistics/1638291/the-commission-has-also-adopted-a-number-of-measures-to-improve-the-quality-of-the-services-provided-by-the-european-union/
Novo Nordisk. "Global Revenue of The Pharmaceutical Group Novo Nordisk from 2007 to 2024 (in Millions of Danish Kroner)." ÌÇÐÄÆƽâ°æ, ÌÇÐÄÆƽâ°æ Inc., 31 Jan 2025, /statistics/1638291/the-commission-has-also-adopted-a-number-of-measures-to-improve-the-quality-of-the-services-provided-by-the-european-union/
Novo Nordisk, Global revenue of the pharmaceutical group Novo Nordisk from 2007 to 2024 (in millions of Danish kroner) ÌÇÐÄÆƽâ°æ, /statistics/1638291/the-commission-has-also-adopted-a-number-of-measures-to-improve-the-quality-of-the-services-provided-by-the-european-union/ (last visited August 06, 2026)
Global revenue of the pharmaceutical group Novo Nordisk from 2007 to 2024 (in millions of Danish kroner) [Graph], Novo Nordisk, January 31, 2025. [Online]. Available: /statistics/1638291/the-commission-has-also-adopted-a-number-of-measures-to-improve-the-quality-of-the-services-provided-by-the-european-union/
